Clinical trial Recruiting at 1 site Interventional Ages 0 Days to 17

Heartsight helps caregivers of kids after cardiac arrest manage uncertainty and fear

Official title: Removing Surrogates Uncertainty to Reduce Fear and Anxiety After Cardiac Events - Kids

Run by Children's Hospital of Philadelphia · NCT07707037 · Data updated 2026-11-12

This pilot trial tests if the Heartsight information program is acceptable and helpful for caregivers of children who recently had a cardiac arrest.

More Cardiac Arrest trials

Quick facts

Study typeInterventional
Ages0 Days to 17 Years
SexAll
Enrollment30 (estimated)
SponsorChildren's Hospital of Philadelphia
Academic / other
Locations1 site (Philadelphia, Pennsylvania)
StatusRecruiting
StartedJune 1, 2026
Main results expectedMay 31, 2027
Study endsMay 31, 2027
Registry record updatedJuly 16, 2026
Trial IDNCT07707037 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are English-speaking caregivers of children under 17.5 years who had a cardiac arrest lasting more than 2 minutes and are nearing discharge within 30 days, with the child currently in PICU/CICU and the caregiver available for participation.

Probably not a fit

Caregivers who do not engage with the information modules or whose child’s condition rapidly improves may experience no measurable benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot randomized trial will enroll up to 30 caregivers of pediatric cardiac arrest patients to test the feasibility and acceptability of the Heartsight informational program. Participants will be randomized in a 2:1 ratio to receive the intervention and usual care, with follow-up at 3 months to assess retention and how often and how long modules are used. Researchers will explore whether the program is associated with changes in caregiver uncertainty and anxiety/depression as a preliminary signal to inform a larger future study. The study is conducted at the Children's Hospital of Philadelphia and focuses on improving family support during the child’s illness trajectory after cardiac arrest.

Why it matters

Potential benefit: If successful, the program could reduce caregiver worry and improve coping during a child’s recovery after cardiac arrest.

How similar studies have gone: Similar informational and caregiver-support approaches have shown feasibility in pediatric critical illness settings, but the specific Heartsight program in this context is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Caregiver

1. Caregiver of a child \<17.5 years of age who had at least a 2 minute cardiac arrest, is expected to be discharged within 30 days, and to survive at least 3 months post-discharge from hospital.
2. English speaking

Child

1. \<17.5 years of age
2. Have had a cardiac arrest lasting more than 2 minutes within the past 7 days and have not yet been discharged from pediatric intensive care unit (PICU) or cardiac intensive care unit (CICU)

Exclusion Criteria:

1\) Parent or legal guardian is not the child's caregiver

Where it's running

  • Children's Hospital of Philadelphia
    Philadelphia, Pennsylvania, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.